几个CVS的风险

2. Court cases like the opioid settlement: CVS announced an agreement to pay about $5 billion over the next 10 years beginning in 2023 to substantially resolve all opioid lawsuits by states, political subdivisions and tribal entities. This, and other similar settlements, will adversely impact EBITDA, profitability and liquidity.
3. Changing public policy: New public policies and regulations implemented by the government may disrupt the existing operations and procedures and ultimately pull on the company’s profitability.
4. Elevated Inflation May Lead to an Increase in Costs: Increasing inflation and higher interest rates are expected to have a negative impact on consumer patterns and increase cost of sales, which may adversely impact profitability.
    CONCLUSION
CVS is a diversified healthcare company with a significant presence in pharmacy services, retail, hea